0000899243-21-008055.txt : 20210224
0000899243-21-008055.hdr.sgml : 20210224
20210224174228
ACCESSION NUMBER: 0000899243-21-008055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210222
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mamluk Roni
CENTRAL INDEX KEY: 0001647053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 21675164
MAIL ADDRESS:
STREET 1: CHIASMA, INC.
STREET 2: 60WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-22
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001647053
Mamluk Roni
OPPENHEIMER 4
REHOVOT
L3
7670104
ISRAEL
1
1
0
0
President & CEO
Common Stock
2021-02-22
4
S
0
15200
19.8561
D
163271
D
Common Stock
2021-02-23
4
S
0
7126
17.8899
D
156145
D
Common Stock
2021-02-24
4
S
0
10800
17.3999
D
145345
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
/s/ Roni Mamluk, Ph.D.
2021-02-24